APSR2026-970

Yes
Late-Breaking
Submitted
Oral Presentation
AO18-006
 
 
https://storage.unitedwebnetwork.com/files/1285/1243255-46903-APSR-Chuhan Zhang_432739.pptx
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Chuhan Zhang * The Affiliated Hospital of Xuzhou Medical University Department of Respiratory and Critical Care Medicine Xuzhou China
Yiying Wang - The Affiliated Hospital of Xuzhou Medical University Department of Respiratory and Critical Care Medicine Xuzhou China
Zhen Feng - The Affiliated Hospital of Xuzhou Medical University Department of Respiratory and Critical Care Medicine Xuzhou China
Bi Chen - The Affiliated Hospital of Xuzhou Medical University Department of Respiratory and Critical Care Medicine Xuzhou China
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Chuhan
Zhang
18921767707@163.com
+8618921767707
Under 30
China
Original Research
Impulse oscillometry parameters predict progressive pulmonary fibrosis in interstitial lung disease
Maximum 25 words
Abstract Content
Small airway dysfunction (SAD) is increasingly recognized in interstitial lung disease (ILD), but its association with progressive pulmonary fibrosis (PPF) remains unclear. Impulse oscillometry (IOS) is a non-invasive, effort-independent tool that may better identify ILD patients at risk of fibrotic progression. This study aimed to evaluate the diagnostic performance of IOS parameters for SAD and their association with PPF in ILD. 小气道功能障碍在间质性肺病中越来越受到重视,但其与进行性肺纤维化之间的关联尚不明确。脉冲振荡测定法是一种无创的、与呼吸努力无关的检测方法,可能有助于更准确地识别那些有纤维化风险的间质性肺病患者。本研究旨在评估脉冲振荡测定法在诊断小气道功能障碍方面的有效性,以及该指标与间质性肺病中的进行性肺纤维化之间的关联。
In this single-center observational cohort study, 255 ILD patients and 51 healthy controls underwent baseline spirometry, diffusion capacity testing, and IOS assessment. SAD was defined using spirometric criteria. Receiver operating characteristic analysis and cross-validation were used to determine IOS cutoffs for SAD. Patients were followed for 12 months to assess PPF according to international guidelines. Multivariable logistic regression was used to analyze the association between IOS-defined SAD and PPF. 在这项单中心观察性队列研究中,255 名 ILD 患者和 51 名健康对照者接受了基线肺功能检测、扩散能力测试以及 IOS 评估。SAD 的诊断标准是根据肺功能检测结果来确定的。通过接收者操作特征分析和交叉验证来确定 SAD 的 IOS 临界值。患者被随访 12 个月,以便根据国际指南评估 PPF 情况。多变量逻辑回归分析被用来研究根据 IOS 标准确定的 SAD 与 PPF 之间的关联。
Compared to controls, ILD patients showed increased peripheral airway resistance and altered pulmonary reactance on IOS. IOS parameters demonstrated moderate diagnostic performance for spirometry-defined SAD (AUC 0.620–0.693). During follow-up, PPF incidence was significantly higher in IOS-defined SAD patients (31.5% vs. 9.9%). AX-defined SAD was independently associated with PPF risk (adjusted OR=5.58, 95% CI: 2.45–13.30, P<0.001). Notably, all 41 patients who developed PPF were classified as SAD by X5, while none of the 179 patients without X5-defined SAD progressed. 与对照组相比,ILD 患者的外周气道阻力更高,肺反应性也有所改变。在 IOS 检测中,这些参数对诊断由肺功能测试所确定的 SAD 具有中等程度的诊断价值(AUC 为 0.620–0.693)。在随访过程中,被 IOS 诊断为 SAD 的患者中,PPF 的发病率明显更高(31.5% vs. 9.9%)。由 AX 方法诊断出的 SAD 也与 PPF 风险相关(调整后的 OR 值为 5.58,95%置信区间为 2.45–13.30,P<0.001)。值得注意的是,所有 41 例发生 PPF 的患者都被 X5 方法诊断为 SAD;而 179 例未被 X5 方法诊断为 SAD 的患者中,没有一人出现 PPF。
IOS parameters, especially AX and X5, effectively identify SAD and predict PPF risk in ILD. AX-defined SAD is an independent risk factor for PPF, while X5 may help exclude low-risk patients. IOS provides prognostic information beyond conventional pulmonary function tests. IOS 参数,尤其是 AX 和 X5,有助于准确识别 SAD,并预测 ILD 患者发生 PPF 的风险。由 AX 所确定的 SAD 是 PPF 的独立风险因素,而 X5 则有助于筛选出低风险患者。IOS 所提供的预后信息,远远超出了传统肺功能检测的范围。
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Interstitial lung disease, Impulse oscillometry, Progressive pulmonary fibrosis
maximum 3 keywords and no abbreviations, separated by commas
This study was supported by the Scientific Research Project of Jiangsu Provincial Health Commission (Grant No. H2023005). The authors declare no competing interests.
321